These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 27437658)

  • 1. Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome.
    Hess PL; Wojdyla DM; Al-Khatib SM; Lokhnygina Y; Wallentin L; Armstrong PW; Roe MT; Ohman EM; Harrington RA; Alexander JH; White HD; Van de Werf F; Piccini JP; Held C; Aylward PE; Moliterno DJ; Mahaffey KW; Tricoci P
    JAMA Cardiol; 2016 Apr; 1(1):73-9. PubMed ID: 27437658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.
    Lopes RD; Leonardi S; Neely B; Neely ML; Ohman EM; Ardissino D; Hamm CW; Goodman SG; Bhatt DL; White HD; Prabhakaran D; Martinez F; Nicolau JC; Winters KJ; Fox KA; Armstrong PW; Roe MT
    J Am Coll Cardiol; 2016 Mar; 67(11):1289-97. PubMed ID: 26988949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
    Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
    Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes.
    Bahit MC; Lopes RD; Clare RM; Newby LK; Pieper KS; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Diaz R; Ohman EM; White HD; James S; Granger CB
    JACC Heart Fail; 2013 Jun; 1(3):223-9. PubMed ID: 24621874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
    Elbarouni B; Ismaeil N; Yan RT; Fox KA; Connelly KA; Baer C; DeYoung JP; Gallo R; Ramanathan K; Pesant Y; Leiter LA; Goodman SG; Yan AT
    Am Heart J; 2011 Aug; 162(2):347-355.e1. PubMed ID: 21835297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
    Armaganijan LV; Alexander KP; Huang Z; Tricoci P; Held C; Van de Werf F; Armstrong PW; Aylward PE; White HD; Moliterno DJ; Wallentin L; Chen E; Harrington RA; Strony J; Mahaffey KW; Lopes RD
    Am Heart J; 2016 Aug; 178():176-84. PubMed ID: 27502866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
    Lefebvre CW; Hoekstra J
    Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes.
    Fanaroff AC; Roe MT; Clare RM; Lokhnygina Y; Navar AM; Giugliano RP; Wiviott SD; Tershakovec AM; Braunwald E; Blazing MA
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28923989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
    Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
    Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of the QRS-T area angle in improving the prediction of sudden cardiac death after acute coronary syndromes.
    Lingman M; Hartford M; Karlsson T; Herlitz J; Rubulis A; Caidahl K; Bergfeldt L
    Int J Cardiol; 2016 Sep; 218():1-11. PubMed ID: 27203188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.
    Clemmensen P; Roe MT; Hochman JS; Cyr DD; Neely ML; McGuire DK; Cornel JH; Huber K; Zamoryakhin D; White HD; Armstrong PW; Fox KA; Prabhakaran D; Ohman EM;
    Am Heart J; 2015 Oct; 170(4):695-705.e5. PubMed ID: 26386793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the relationship between renal resistive index and extent and complexity of coronary artery disease in patients with acute coronary syndrome.
    Quisi A; Kurt IH; Şahin DY; Kaypaklı O; Söker G; Kaya Ö; Allahverdiyev S; Genç Ö; Alıcı G; Koç M
    Kardiol Pol; 2017; 75(11):1199-1207. PubMed ID: 28715070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
    Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
    Liu SC; Yi TC; Weng HY; Zhang L; Li YX; Mohetaboer M; Zhang Y; Jiang J; Li JP; Huo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):284-291. PubMed ID: 29747324
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).
    Harkness JR; Morrow DA; Braunwald E; Ren F; Lopez-Sendon J; Bode C; Budaj A; Scirica BM
    Am J Cardiol; 2011 Nov; 108(10):1373-81. PubMed ID: 21890090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine.
    Karwatowska-Prokopczuk E; Wang W; Cheng ML; Zeng D; Schwartz PJ; Belardinelli L
    Europace; 2013 Mar; 15(3):429-36. PubMed ID: 23258816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary practice and outcomes of an elderly cohort of Japanese patients with non-ST-elevation acute coronary syndrome in the era of routine early invasive strategy.
    Nagata T; Hyakuna Y; Miyata K; Mohri M
    Int J Cardiol; 2017 Aug; 240():49-54. PubMed ID: 28416248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.